Insights
Practices
Type
People
Most recent
Axinn is proud to announce that Lawdragon has recognized 15 of our attorneys in its 2025 edition of the Lawdragon 500 X – The Next Generation guide.
On July 15, 2025, Judge Evelyn Padin of the District of New Jersey denied Novartis’s motion for preliminary injunction, which would have blocked MSN Laboratories Pvt. Ltd. from selling a generic version of Novartis’s Entresto based on alleged trade dress infringement.
Axinn partner Scott Eisman and associate Isabella Schwarze co-authored the New York Law Journal article, “NY Court of Appeals: Key Business Decisions from the Past Term.”
Axinn is proud to announce that Lawdragon has recognized 15 of our attorneys in its 2025 edition of the Lawdragon 500 X – The Next Generation guide.
On July 15, 2025, Judge Evelyn Padin of the District of New Jersey denied Novartis’s motion for preliminary injunction, which would have blocked MSN Laboratories Pvt. Ltd. from selling a generic version of Novartis’s Entresto based on alleged trade dress infringement.
Axinn partner Scott Eisman and associate Isabella Schwarze co-authored the New York Law Journal article, “NY Court of Appeals: Key Business Decisions from the Past Term.”
Axinn is proud to announce that Lawdragon has recognized 15 of our attorneys in its 2025 edition of the Lawdragon 500 X – The Next Generation guide.
© 2025 Axinn, Veltrop & Harkrider LLP. All Rights Reserved
Back to top